drotrecogin alfa Latest Research Papers

Drotrecogin Alfa (Activated)

10.32388/pyfvot ◽

2020 ◽

Author(s):

Keyword(s):

Drotrecogin Alfa ◽

Drotrecogin Alfa Activated

Download Full-text

Orphan designation: drotrecogin alfa (activated), Treatment of acute respiratory distress syndrome (ARDS)

Case Medical Research ◽

10.31525/cmr-21bf3e6 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Drotrecogin Alfa ◽

Distress Syndrome ◽

Orphan Designation ◽

Drotrecogin Alfa Activated

Download Full-text

Orphan designation: drotrecogin alfa (activated), Treatment of acute respiratory distress syndrome (ARDS)

Case Medical Research ◽

10.31525/cmr-21cb18f ◽

2019 ◽

Author(s):

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Drotrecogin Alfa ◽

Distress Syndrome ◽

Orphan Designation ◽

Drotrecogin Alfa Activated

Download Full-text

Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis

Annals of Intensive Care ◽

10.1186/s13613-018-0353-2 ◽

2018 ◽

Vol 8 (1) ◽

Cited By ~ 2

Author(s):

Djillali Annane ◽

Jean-Paul Mira ◽

Lorraine B. Ware ◽

Anthony C. Gordon ◽

Charles J. Hinds ◽

...

Keyword(s):

Severe Sepsis ◽

Drotrecogin Alfa

Download Full-text

Adoption and de-adoption of drotrecogin alfa for severe sepsis in the United States

Journal of Critical Care ◽

10.1016/j.jcrc.2015.12.007 ◽

2016 ◽

Vol 32 ◽

pp. 114-119 ◽

Cited By ~ 9

Author(s):

Jeremy M. Kahn ◽

Tri Q. Le

Keyword(s):

United States ◽

Severe Sepsis ◽

Drotrecogin Alfa ◽

The United States

Download Full-text

Drotrecogin alfa

Meyler's Side Effects of Drugs ◽

10.1016/b978-0-444-53717-1.00078-0 ◽

2016 ◽

pp. 1097-1098

Keyword(s):

Drotrecogin Alfa

Download Full-text

DROTRECOGIN ALFA

Litt's Drug Eruptions and Reactions Manual ◽

10.1201/b15347-66 ◽

2014 ◽

pp. 150-151

Keyword(s):

Drotrecogin Alfa

Download Full-text

Safety and Dose-Finding Study of Activated Protein C (Drotrecogin Alfa Activated) as an Anticoagulant in End-Stage Renal Disease Patients Treated with Hemodialysis

Blood Purification ◽

10.1159/000362154 ◽

2014 ◽

Vol 37 (3) ◽

pp. 243-248 ◽

Cited By ~ 1

Author(s):

Ermira Brasha-Mitchell ◽

Ashte Collins ◽

Lindita Shehu ◽

Michael G. Seneff ◽

Samir S. Patel ◽

...

Keyword(s):

End Stage Renal Disease ◽

Protein C ◽

Drotrecogin Alfa ◽

Activated Protein C ◽

Dose Finding ◽

Drotrecogin Alfa Activated ◽

Finding Study ◽

Dose Finding Study ◽

Stage Renal Disease ◽

End Stage

Download Full-text

Decreasing mortality with drotrecogin alfa in high risk septic patients A meta-analysis of randomized trials in adult patients with multiple organ failure and mortality >40%

Signa Vitae - A Journal In Intensive Care And Emergency Medicine ◽

10.22514/sv91.042014.2 ◽

2014 ◽

Vol 9 (1) ◽

pp. 16 ◽

Cited By ~ 1

Keyword(s):

High Risk ◽

Multiple Organ Failure ◽

Organ Failure ◽

Randomized Trials ◽

Drotrecogin Alfa ◽

Meta Analysis ◽

Multiple Organ ◽

Adult Patients

Download Full-text

The quest for the magic bullet: Centoxin, Drotrecogin Alfa and lessons not learned

Trends in Anaesthesia and Critical Care ◽

10.1016/j.tacc.2013.05.004 ◽

2013 ◽

Vol 3 (6) ◽

pp. 316-319 ◽

Cited By ~ 4

Author(s):

Stephen T. Murphy ◽

Mark C. Bellamy

Keyword(s):

Drotrecogin Alfa ◽

Magic Bullet

Download Full-text

drotrecogin alfa
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Drotrecogin Alfa (Activated)

Orphan designation: drotrecogin alfa (activated), Treatment of acute respiratory distress syndrome (ARDS)

Orphan designation: drotrecogin alfa (activated), Treatment of acute respiratory distress syndrome (ARDS)

Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis

Adoption and de-adoption of drotrecogin alfa for severe sepsis in the United States

Drotrecogin alfa

DROTRECOGIN ALFA

Safety and Dose-Finding Study of Activated Protein C (Drotrecogin Alfa Activated) as an Anticoagulant in End-Stage Renal Disease Patients Treated with Hemodialysis

Decreasing mortality with drotrecogin alfa in high risk septic patients A meta-analysis of randomized trials in adult patients with multiple organ failure and mortality >40%

The quest for the magic bullet: Centoxin, Drotrecogin Alfa and lessons not learned

Export Citation Format

drotrecogin alfaRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Drotrecogin Alfa (Activated)

Orphan designation: drotrecogin alfa (activated), Treatment of acute respiratory distress syndrome (ARDS)

Orphan designation: drotrecogin alfa (activated), Treatment of acute respiratory distress syndrome (ARDS)

Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis

Adoption and de-adoption of drotrecogin alfa for severe sepsis in the United States

Drotrecogin alfa

DROTRECOGIN ALFA

Safety and Dose-Finding Study of Activated Protein C (Drotrecogin Alfa Activated) as an Anticoagulant in End-Stage Renal Disease Patients Treated with Hemodialysis

Decreasing mortality with drotrecogin alfa in high risk septic patients A meta-analysis of randomized trials in adult patients with multiple organ failure and mortality >40%

The quest for the magic bullet: Centoxin, Drotrecogin Alfa and lessons not learned

drotrecogin alfa
Recently Published Documents